{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:34:23Z","timestamp":1785461663671,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.anai.2015.12.026","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T09:30:17Z","timestamp":1453714217000},"page":"321-328.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease"],"prefix":"10.1016","volume":"116","author":[{"given":"Elina","family":"Jerschow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golda","family":"Hudes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Spivack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenstreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2015.12.026_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A\u00a0controlled study of 9\u03b1,11\u03b2-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib4","series-title":"Leukotrienes as Mediators of Asthma Induced by Aspirin and Allergen","author":"Dahlen","year":"1993"},{"key":"10.1016\/j.anai.2015.12.026_bib5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","article-title":"Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics","volume":"146","author":"Klumlin","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.anai.2015.12.026_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2015.12.026_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2015.12.026_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0091-6749(95)70002-1","article-title":"Inhibition of monocyte leukotriene B4 production after aspirin desensitization","volume":"96","author":"Juergens","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0091-6749(92)90137-Q","article-title":"Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge","volume":"90","author":"Juergens","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"A\u00a0dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaci.2011.09.019","article-title":"Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis","volume":"129","author":"Higashi","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(96)70167-7","article-title":"Increased urinary excretion of the prostaglandin D2 metabolite 9 \u03b1, 11 \u03b2-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction","volume":"98","author":"O'Sullivan","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib17","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.12.026_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease","volume":"3","author":"Chen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2015.12.026_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1398-9995.2004.00502.x","article-title":"Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma","volume":"59","author":"Rolla","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.12.026_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/ajra.2012.26.3818","article-title":"Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease","volume":"26","author":"Tworek","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.anai.2015.12.026_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl","key":"10.1016\/j.anai.2015.12.026_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows: report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2015.12.026_bib25","series-title":"Clement Clarke International Catalogue","author":"Clement Clarke International Ltd","year":"2015"},{"key":"10.1016\/j.anai.2015.12.026_bib26","series-title":"Cystenyl Leukotriene EIA Kit","year":"2010"},{"key":"10.1016\/j.anai.2015.12.026_bib27","series-title":"Tetranor-PGDM EIA Kit","year":"2010"},{"key":"10.1016\/j.anai.2015.12.026_bib28","series-title":"Prostaglandin E Metabolite EIA Kit","year":"2010"},{"key":"10.1016\/j.anai.2015.12.026_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.12.026_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaci.2013.12.1070","article-title":"Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes","volume":"134","author":"Haccuria","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib32","doi-asserted-by":"crossref","first-page":"e90018","DOI":"10.1371\/journal.pone.0090018","article-title":"Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS","volume":"9","author":"Roos","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.anai.2015.12.026_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.rmed.2014.02.005","article-title":"Current evidence and future research needs for FeNO measurement in respiratory diseases","volume":"108","author":"Bjermer","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2015.12.026_bib34","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The l-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.12.026_bib35","first-page":"109","article-title":"Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma","volume":"46","author":"Giovannini","year":"2014","journal-title":"Eur Annals Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib36","doi-asserted-by":"crossref","first-page":"L987","DOI":"10.1152\/ajplung.00063.2014","article-title":"Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury","volume":"307","author":"Wu","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.anai.2015.12.026_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1755.1998.00791.x","article-title":"Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury","volume":"53","author":"Lianos","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.anai.2015.12.026_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.12.026_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1164\/ajrccm.161.2.9902034","article-title":"Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients","volume":"161","author":"Kowalski","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2015.12.026_bib42","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2013.12.1034","article-title":"Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease","volume":"133","author":"Laidlaw","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib43","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anai.2015.12.026_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.12.026_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2332\/allergolint.O-08-545","article-title":"Correlation between the prostaglandin D(2)\/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma","volume":"57","author":"Yoshimura","year":"2008","journal-title":"Allergol Intl"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615008479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615008479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:13:54Z","timestamp":1761052434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120615008479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1081120615008479"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2015.12.026","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2015.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}